Future Microbiology

Papers
(The H4-Index of Future Microbiology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)79
Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid60
Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children54
Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB47
In vitrodetection of porphyrin-producing wound bacteria with real-time fluorescence imaging47
Cell division protein FtsZ: from structure and mechanism to antibiotic target47
N-acetylcysteine as a potential treatment for COVID-1945
Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis40
Systemic mycoses: a potential alert for complications in COVID-19 patients34
Nanoparticulate drug-delivery systems for fighting microbial biofilms: from bench to bedside34
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: an emerging tool for studying the vectors of human infectious diseases32
Quorum-sensing regulation of virulence factors in bacterial biofilm30
Tackling antimicrobial resistance by exploring new mechanisms of antibiotic action30
COVID-19: it's all about sepsis29
Review of the use of nasal and oral antiseptics during a global pandemic29
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients29
Rezafungin: a novel antifungal for the treatment of invasive candidiasis28
Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections28
Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing Enterobacterales26
Antivirulence compounds: a future direction to overcome antibiotic resistance?26
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV25
Focus on the 2019 novel coronavirus (SARS-CoV-2)25
Silver nanoparticles stabilized with propolis show reduced toxicity and potential activity against fungal infections24
Phages in the fight against COVID-19?24
0.039615869522095